Adjuvant Immunochemotherapy with Protein-Bound Polysaccharide K for Colon Cancer in Relation to Oncogenic β-Catenin Activation

Kaname Yamashita1, Andrei V. Ougolkov1, 2, Hiroaki Nakazato3, Katsuki Ito3, Yasuo Ohashi3, Hidekazu Kitakata1, Kazuo Yasumoto1, Kazuhiko Omote1, Masayoshi Mai1, Yutaka Takahashi1 and Toshinari Minamoto1

(1) Divisions of Translational and Clinical Oncology and Surgical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
(2) Division of Developmental Oncology Research, Mayo Clinic, Rochester, Minnesota, USA
(3) The Study Group of Colon Cancer Immunochemotherapy with PSK and 5-FU (CIP), Aichi, Japan
(4) Division of Translational and Clinical Oncology (previously, Division of Diagnostic Molecular Oncology) and Surgical Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-0934, Japan

Published online: 2 June 2007